Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.262
Buy
RSI(14)
50.152
Neutral
STOCH(KDJ)(9,3,3)
62.741
Neutral
ATR(14)
2.997
High Vlolatility
CCI(14)
31.661
Neutral
Williams %R
58.302
Sell
TRIX(12,20)
-0.008
Sell
StochRSI(14)
0.000
Sell
Integer Holdings Corp
ITGR85.330USD
-1.500-1.73%
Close 03/27, 16:00（ET）Quotes delayed by 15 min
2.86BMarket Cap
28.83P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Integer Holdings Corp
Currency: USD Updated: 2026-03-27Key Insights
Integer Holdings Corp's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 67 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 93.25.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Integer Holdings Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Integer Holdings Corp Highlights
StrengthsRisks
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 19.15% year-on-year.
Undervalued
The company’s latest PE is 28.83, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 39.33M shares, decreasing 11.01% quarter-over-quarter.
Held by Barrow Hanley
Star Investor Barrow Hanley holds 220.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.25.
Analyst Rating
Based on
11
analysts
Hold
Current Rating
93.250
Target Price
+8.19%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-03-27The current financial score of Integer Holdings Corp is 7.49, ranking 70 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 472.06M, representing a year-over-year increase of 5.02%, while its net profit experienced a year-over-year increase of 48.63%.
Score
Financials
5.63
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.92
Operational Efficiency
7.74
Growth Potential
8.76
Shareholder Returns
7.40
Integer Holdings Corp's Company Valuation
Currency: USD Updated: 2026-03-27The current valuation score of Integer Holdings Corp is 5.47, ranking 183 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 28.83, which is 92.04% below the recent high of 55.36 and 13.33% above the recent low of 24.99.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 67/208
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-03-27The current earnings forecast score of Integer Holdings Corp is 6.91, ranking 158 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 86.00, with a high of 95.00 and a low of 69.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
11
analysts
Hold
Current Rating
93.250
Target Price
+8.19%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
92
Total
4
Median
7
Average
Company name
Ratings
Analysts
Integer Holdings Corp
ITGR
11
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
36
Edwards Lifesciences Corp
EW
35
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
29
1
2
3
...
19
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-03-27The current price momentum score of Integer Holdings Corp is 7.03, ranking 39 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 89.56 and the support level at 81.55, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
86.088
Sell
MA10
85.493
Sell
MA20
85.186
Buy
MA50
85.672
Sell
MA100
79.696
Buy
MA200
93.206
Sell
Institutional Confidence
Currency: USD Updated: 2026-03-27The current institutional shareholding score of Integer Holdings Corp is 10.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 112.26%, representing a quarter-over-quarter decrease of 3.74%. The largest institutional shareholder is The Vanguard, holding a total of 3.88M shares, representing 11.27% of shares outstanding, with 4.37% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Dimensional Fund Advisors, L.P.
State Street Investment Management (US)
AllianceBernstein L.P.
Invesco Advisers, Inc.
EARNEST Partners, LLC
Geode Capital Management, L.L.C.
1
2
Risk Assessment
Currency: USD Updated: 2026-03-27The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Integer Holdings Corp is 4.56, ranking 103 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.74. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
0.74
VaR
+2.94%
240-Day Maximum Drawdown
+50.11%
240-Day Volatility
+45.82%
Return
Best Daily Return
60 days
+3.83%
120 days
+5.92%
5 years
+15.59%
Worst Daily Return
60 days
-4.02%
120 days
-32.28%
5 years
-32.28%
Sharpe Ratio
60 days
+1.50
120 days
-0.40
5 years
+0.13
Risk Assessment
Maximum Drawdown
240 days
+50.11%
3 years
+56.14%
5 years
+56.14%
Return-to-Drawdown Ratio
240 days
-0.53
3 years
+0.05
5 years
-0.03
Skewness
240 days
-7.36
3 years
-4.24
5 years
-2.80
Volatility
Realised Volatility
240 days
+45.82%
5 years
+35.86%
Standardised True Range
240 days
+3.30%
5 years
+3.10%
Downside Risk-Adjusted Return
120 days
-30.56%
240 days
-30.56%
Maximum Daily Upside Volatility
60 days
+36.82%
Maximum Daily Downside Volatility
60 days
+18.19%
Liquidity
Average Turnover Rate
60 days
+1.16%
120 days
+1.53%
5 years
--
Turnover Deviation
20 days
-24.92%
60 days
+12.07%
120 days
+47.75%
Peer Comparison
Healthcare Equipment & Supplies
Integer Holdings Corp
ITGR
6.94 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bioventus Inc
BVS
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.05 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
